Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Argus Health
Johnson and Johnson
Moodys
Boehringer Ingelheim
US Department of Justice

Generated: May 25, 2019

DrugPatentWatch Database Preview

JETREA Drug Profile

« Back to Dashboard

Summary for Tradename: JETREA
Patents:8
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for JETREA
Ingredient-typePeptide Hydrolases

US Patents for JETREA

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Thrombogenics, Inc JETREA ocriplasmin INJECTABLE; INTRAVITREAL 125422 001 2012-10-17 ➤ Try a Free Trial Wayne State University (Detroit, MI) ➤ Try a Free Trial RX search
Thrombogenics, Inc JETREA ocriplasmin INJECTABLE; INTRAVITREAL 125422 001 2012-10-17 ➤ Try a Free Trial OcuJect, LLC (Newport Beach, CA) ➤ Try a Free Trial RX search
Thrombogenics, Inc JETREA ocriplasmin INJECTABLE; INTRAVITREAL 125422 001 2012-10-17 ➤ Try a Free Trial OcuJect, LLC (Newport Beach, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for JETREA

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2013/042 Ireland ➤ Try a Free Trial PRODUCT NAME: MICROPLASMIN; REGISTRATION NO/DATE: EU/1/13/819/001 20130315
92273 Luxembourg ➤ Try a Free Trial PRODUCT NAME: MICROPLASMIN
2013C/055 Belgium ➤ Try a Free Trial DETAILS ASSIGNMENT: CHANGE OF OWNER(S), CHANGEMENT DE NOM DU PROPRIETAIRE
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Covington
Cantor Fitzgerald
US Army
Deloitte
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.